In 2018, Merck is determined to step up for patients ... For these reasons, before and during the clinical trial design process, our researchers are attentive to patients’ interests, their ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Are you a print subscriber? Activate your account. By Garett Sloane - 37 min 55 sec ago By Ewan Larkin - 1 hour 7 min ago By E.J. Schultz - 1 hour 7 min ago By Tim Nudd - 1 hour 7 min ago By Brian ...

This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...

On Oct. 25, the City of Rahway unveiled a 1,500-square-foot mural that pays homage to three groundbreaking figures with ties ...

Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.